Food and Drugs Act
Version of section 21.71 from 2020-05-23 to 2024-10-30:
Marginal note:Duty to publicize clinical trial information
21.71 The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time and in the prescribed manner.
- 2014, c. 24, s. 3
- 2019, c. 29, s. 168
- Date modified: